Science in Cardiovascular Diseases

Get a 360º view and stay up-to-date on cardiovascular disease with content selected for you

ODYSSEY Outcomes

NEJM Odyssey Outcomes

Odyssey Outcomes - Mortality

Odyssey Outcomes - CABG Results

Odyssey Outcomes - PVD Results

PCSK9 inhibitors and ACS

Changing trends in VTE: Pulmonary Embolism Cases on Rise within the Last Decade

VTE Comparison of Pregnancy-Specific Risk Scoring Systems in Hospitalized Maternity Patients

Utility of Pregnancy-Adapted YEARS Algorithm in Diagnosis of Pulmonary Embolism

Clopidogrel Based Strategies in ACS

Clopidogrel vs Ticagrelor in ACS

P2Y12 Inhibitors After Coronary Stenting

SEE EVERYTHING

Inspiration and innovation

Get inspired and stay at the forefront of innovation with the following resources

PCSK9 inhibitors and ACS

VTE Comparison of Pregnancy-Specific Risk Scoring Systems in Hospitalized Maternity Patients

Utility of Pregnancy-Adapted YEARS Algorithm in Diagnosis of Pulmonary Embolism

Key Learnings in Dyslipidemia by Prof. Kausik Ray - 2021 EAS Congress

Clinical practice experience in patients with familial hypercholesterolemia (FH) from the SAFEHEART registry

Atherosclerotic Cardiovascular Disease Risk Assessment

PCSK9 Inhibitors in Cardiovascular Disease

PCSK9i and Prevention of CVD

APSC Consensus Recommendations on Dyslipidemia

VTE prophylaxis in medically ill patients

VTE Risk Assessment in Surgical Patients

Atherosclerosis: Identifying risks and improving outcomes

SEE EVERYTHING

Events

Stay up to date and register for the latest events and view webinar recordings.

Venous Thromboembolism Burden

Sanofi Thrombosis Summit

24:30

Dyslipidemia Webinars: Optimizing Dyslipidemia management​

VTE prevention for acutely ill patients

Challenges of VTE Prophylaxis in Surgery

Dyslipidemia Webisodes: Mortality data with Prof. Tunon

Venous Thromboembolism in Acutely Medically Ill Patients

Hypertension - The Most Important Disease in Medicine

Hypertension - The Most Important Disease in Medicine II

Dyslipidemia Expert Exchange: Best practice approaches in dyslipidemia management

19:24

VTE Safety Zone: Assessing the VTE Risk in Hospital and Beyond

06:13

VTE Safety Zone: The Role of Thromboprophylaxis for the Prevention of VTE

SEE EVERYTHING